GreatBanc Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$642K Sell
535
-5
-0.9% -$5.11K 0.4% 27
2026
Q1
$497K Sell
540
-15
-3% -$15.2K 0.35% 34
2025
Q4
$596K Sell
555
-6
-1% -$5.74K 0.42% 29
2025
Q3
$428K Buy
+561
New +$417K 0.29% 43

Other funds holding LLY

GreatBanc Trust's LLY Position: Q2 2026 in Review

GreatBanc Trust reduced its Eli Lilly (LLY) stake by 0.93% in Q2 2026, selling an estimated $5.11K and leaving 535 shares worth $642K. The position accounts for 0.4% of the portfolio, ranked #27.

GreatBanc Trust first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GreatBanc Trust held 535 shares of Eli Lilly worth $642K as of Q2 2026.
  • GreatBanc Trust sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.4% of GreatBanc Trust's portfolio in Q2 2026, its #27 holding.
  • GreatBanc Trust first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GreatBanc Trust's 13F filing for Q2 2026, filed 30 Jul 2026.